U.S. Markets close in 3 hrs 34 mins

Direxion to Split 19 ETFs, Including Eight Reverse Splits


Direxion, the second-largest issuer of invers and leveraged exchange traded funds, said today it is splitting 19 of its geared funds. The splits include eight reverse splits and 11 traditional, or forward splits.

Direxion will reverse split the Direxion Daily Brazil Bull 3x Shares (BRZU) , Direxion Daily FTSE China Bear 3X Shares (YANG) and the Direxion Daily Natural Gas Related Bull 3X (GASL) on a 1-for-10 basis. Five other Direxion ETFs will be reverse split on a 1-for-four basis.

Those splits will be effective at the open of the market on May 20, 2015, according to a statement issued by Direxion.


Table Courtesy: Direxion

Of the 11 ETFs undergoing forward splits, 10 will be split 4-for-1 while the Direxion Daily 7-10 Treasury Bull 2x Shares (SYTL) will be split 2-for-1. SYTL, which debuted in late July, attempts to deliver 200% of the daily performance of the NYSE 7-10 Year Treasury Bond Index (AXSVTN). That ETF was reverse split 1-for-2 in November. [Upcoming Reverse Splits for Leveraged ETFs]

“All forward share splits will apply to shareholders of record as of the close of the NYSE Arca on May 18, 2015 (the “Record Date”), payable after the close of the NYSE Arca on May 19, 2015 (the “Payable Date”).  Shares of the Funds will begin trading on the NYSE Arca on a split-adjusted basis on May 20, 2015,” according to Direxion.

Among the well-known ETFs being forward split by Direxion are the Direxion Daily Healthcare Bull 3x Shares (CURE), Direxion Daily Technology Bull 3X Shares (NYSEArca: TECL) and the Direxion Daily India Bull 3X Shares (INDL) . [Living Large With a Leveraged India ETF]


Table Courtesy: Direxion

ETF Trends editorial team contributed to this post.

The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.